- Home
- PLX vs VFL Comparison
PLX vs VFL Comparison
Compare PLX & VFL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PLX
- VFL
- Stock Information
- Founded
- PLX 1993
- VFL 1993
- Country
- PLX United States
- VFL United States
- Employees
- PLX N/A
- VFL N/A
- Industry
- PLX Biotechnology: Biological Products (No Diagnostic Substances)
- VFL Finance/Investors Services
- Sector
- PLX Health Care
- VFL Finance
- Exchange
- PLX Nasdaq
- VFL Nasdaq
- Market Cap
- PLX 127.4M
- VFL 116.3M
- IPO Year
- PLX 1998
- VFL N/A
- Fundamental
- Price
- PLX $1.55
- VFL $9.69
- Analyst Decision
- PLX Strong Buy
- VFL
- Analyst Count
- PLX 1
- VFL 0
- Target Price
- PLX $15.00
- VFL N/A
- AVG Volume (30 Days)
- PLX 571.5K
- VFL 38.0K
- Earning Date
- PLX 08-14-2025
- VFL 01-01-0001
- Dividend Yield
- PLX N/A
- VFL 4.16%
- EPS Growth
- PLX N/A
- VFL N/A
- EPS
- PLX 0.08
- VFL N/A
- Revenue
- PLX $61,948,000.00
- VFL N/A
- Revenue This Year
- PLX $14.53
- VFL N/A
- Revenue Next Year
- PLX $75.77
- VFL N/A
- P/E Ratio
- PLX $20.34
- VFL N/A
- Revenue Growth
- PLX 62.79
- VFL N/A
- 52 Week Low
- PLX $0.89
- VFL $7.93
- 52 Week High
- PLX $3.10
- VFL $10.77
- Technical
- Relative Strength Index (RSI)
- PLX 47.97
- VFL 61.88
- Support Level
- PLX $1.47
- VFL $9.53
- Resistance Level
- PLX $1.57
- VFL $9.65
- Average True Range (ATR)
- PLX 0.07
- VFL 0.09
- MACD
- PLX -0.00
- VFL 0.01
- Stochastic Oscillator
- PLX 31.82
- VFL 92.86
About PLX Protalix BioTherapeutics Inc. (DE)
Protalix BioTherapeutics Inc is a biopharmaceutical company focused on the development and commercialization of recombinant therapeutic proteins based on its proprietary ProCellEx protein expression system or ProCellEx. It has developed taliglucerase alfa for the treatment of Gaucher disease. The company's products also treat diseases like Fabry disease and cystic fibrosis. The company's primary sources of revenue include its sales of BioManguinhos alfataliglicerase in Brazil and of drug substances to Pfizer under its Amended Pfizer Agreement. The company's pipeline consists of ELFABRIO, Uricase, and Long Acting DNase I.
About VFL abrdn National Municipal Income Fund
Delaware Investments Natl Muni Income is a closed-end investment fund. The Fund seeks to provide current income exempt from regular federal income tax consistent with the preservation of capital. The company's product portfolio includes Mutual funds, Exchange-traded funds, Private markets, Delaware Funds by Macquarie Premier Models, Managed accounts, Closed-end funds, and Variable Insurance Products.